In today’s edition of Catalan newspaper Ara, IBEC associate director Josep Samitier is interviewed for a full-page feature. In it, he tells journalist Joan García about the history and goals of IBEC, its successes and the challenges it faces.
Biomechanics and mechanobiology group leader Damien Lacroix has been awarded a prestigious European Research Council (ERC) Starting Grant for his research on finite element simulations of mechanobiology in tissue engineering.
Processes like tissue regeneration and cancer metastasis rely on groups of cells moving long distances without losing their cohesiveness, but how they do this has remained unknown. Now researchers from the Institute for Bioengineering of Catalonia (IBEC) and Harvard University have solved the mystery and unveiled a brand new phenomenon in biology.
A press conference to present BioNanoMed Catalunya, the IBEC-led alliance created to promote nanotechnology applied to healthcare and biotechnology, was held on Friday at the Museu Colet in Barcelona.
The official press launch of BioNanoMed Catalunya, the IBEC-led platform to promote synergies between groups, universities, hospitals and companies doing research in nanotechnology applied to health and biotechnology, featured in the lunchtime news on TV3 on 13 May.
Some of IBEC’s research got some constructive feedback last week with the annual visit of members of the institute’s International Scientific Committee (ISC).
IBEC group leader Ángel Raya is quoted in an article in La Vanguardia about recent research from Harvard that has discovered a cell type previously unknown in the human body.
Postdoc researcher in the Nanobioengineering group Toni Homs was asked to give some feedback to be published on the website of the collaborative project Interbio.
An article entitled “Nanomedicine, the key to early diagnosis” including an interview with IBEC associate director Josep Samitier appears in Diario Medico.